Current Opinion in Behavioral Sciences, published by ELSEVIER, is a premier academic journal that provides insightful and comprehensive reviews of contemporary research in the fields of behavioral neuroscience, cognitive neuroscience, and psychiatry and mental health. With an impressive Q1 ranking in multiple categories and Scopus rankings that highlight its influence—4th in Behavioral Neuroscience and 8th in Cognitive Neuroscience—this journal has positioned itself as a leading platform for disseminating high-quality scholarly work. Accessible to readers in the United Kingdom and beyond, it plays a vital role in advancing knowledge and understanding of behavioral science and its applications. Its impact is further underscored by its percentile rankings in key fields, making it an essential resource for researchers, professionals, and students seeking to stay abreast of the latest developments and trends from 2015 to 2024. This journal aims to bridge the gap between cutting-edge research and practical application, fostering a collaborative and interdisciplinary approach to pressing issues in behavioral sciences.

PSYCHONEUROENDOCRINOLOGY is a leading journal published by PERGAMON-ELSEVIER SCIENCE LTD, dedicated to advancing the understanding of the interplay between psychological, neurological, and endocrine systems. Since its inception in 1975, the journal has emerged as a critical resource for researchers in fields such as biological psychiatry, endocrinology, and neuroscience, achieving prestigious quartile rankings including Q1 in Endocrine and Autonomic Systems and Q1 in Psychiatry and Mental Health as of 2023. With a strong focus on original research and comprehensive reviews, PSYCHONEUROENDOCRINOLOGY fosters an engaging platform for the exchange of innovative ideas, findings, and methodologies. Although not an open access journal, it provides broad access through institutional subscriptions, making it an invaluable asset for students, professionals, and researchers alike, keen to delve into the latest developments in this interdisciplinary field. With an impressive Scopus ranking and high percentiles across multiple categories, this journal stands at the forefront of scientific inquiry pertaining to the intricate relationships between mind and body, paving the way for novel therapeutic approaches and enhancing our understanding of mental health disorders.

HORMONE AND METABOLIC RESEARCH, published by GEORG THIEME VERLAG KG, stands as a reputable platform in the fields of biochemistry, endocrinology, and metabolism since its establishment in 1969. This peer-reviewed journal provides critical insights and advancements in the intricate relationships between hormones and metabolic processes, catering to researchers, healthcare professionals, and students alike. With an impressive convergence of knowledge spanning over five decades, it maintains a commendable Q3 ranking in multiple categories, including Biochemistry, Clinical Biochemistry, and Endocrinology, highlighting its contribution to cutting-edge scientific discourse. Although not an open-access journal, it offers a plethora of access options for readers and institutions, ensuring that vital research reaches those who need it most. Located in Stuttgart, Germany, the journal is positioned at the forefront of influential research in hormone and metabolic studies, emphasizing its importance for ongoing investigations into health and disease.

PHYSIOLOGY & BEHAVIOR, published by Pergamon-Elsevier Science Ltd, is a premier journal that has been illuminating the intersections of physiological and behavioral research since its inception in 1966. With a promising impact reflected in its 2023 category quartiles— ranking Q2 in both Behavioral Neuroscience and Experimental and Cognitive Psychology, and a prior Q1 in Philosophy—this journal stands at the forefront of multidisciplinary research. It holds respectable ranks within the Scopus database, placing 27th out of 165 in Experimental Psychology and 25th out of 88 in Behavioral Neuroscience, highlighting its significant contribution to the academic community. The journal encourages the dissemination of high-quality research objectives that explore the intricate connections between behavior and biological processes, making it a vital resource for researchers, professionals, and students alike. Although access is not currently open, the journal continues to provide deep insights into crucial developments in its field, ensuring its readers stay updated on the latest scientific advancements.

Hormone Molecular Biology and Clinical Investigation, published by WALTER DE GRUYTER GMBH, is a pivotal journal within the realms of Endocrinology, Diabetes and Metabolism, and Molecular Biology, contributing significant insights to the field since its inception in 2010. With an ISSN of 1868-1883 and an E-ISSN of 1868-1891, this esteemed journal operates from its headquarters in Berlin, Germany. As a further testament to its growing influence, the journal has achieved respectable category quartile rankings in 2023, including Q3 in Endocrinology, Diabetes and Metabolism and Medicine (miscellaneous), alongside Q4 in Molecular Biology. While currently not open access, the journal is dedicated to disseminating high-quality research aimed at understanding hormone-related mechanisms, clinical applications, and the biochemical pathways that underpin human health. The rich variety of articles published in Hormone Molecular Biology and Clinical Investigation make it an invaluable resource for researchers, medical professionals, and students seeking to deepen their knowledge in these critical scientific areas.

Reproductive Biology and Endocrinology, published by BMC, is a distinguished open-access journal established in 2003, catering to researchers and professionals in the interdisciplinary fields of reproductive biology, endocrinology, and related biomedical sciences. With a notable impact in 2023, the journal has achieved Q1 rankings in Obstetrics and Gynecology, Reproductive Medicine, and Endocrinology, alongside a Q2 ranking in Developmental Biology, establishing itself as a pivotal source of high-quality research and insights. The journal's commitment to freely accessible research promotes knowledge dissemination across its domains, which is crucial for advancing understanding of reproductive health and endocrine mechanisms. With a robust Scopus ranking showcasing its relevance—17th out of 209 in Obstetrics and Gynecology, and 8th out of 90 in Reproductive Medicine—it serves as an essential resource for academics and clinicians alike, facilitating innovative research and fostering collaboration within the global scientific community.

PROGRESS IN NEUROBIOLOGY is a prestigious journal dedicated to advancing the field of neuroscience, published by Pergamon-Elsevier Science Ltd. With an impressive impact factor, it stands as a critical resource for researchers, professionals, and students alike, featuring rigorous peer-reviewed articles that explore the latest developments in neurobiology. The journal has established itself as a leading publication, ranked in the Q1 category for Neuroscience (miscellaneous) and holding a notable 13/113 rank in General Neuroscience per Scopus metrics, placing it in the top 12% of its field. Since its inception in 1959, PROGRESS IN NEUROBIOLOGY has covered a wide array of topics, from molecular mechanisms to cognitive processes, fostering a comprehensive understanding of brain functions. While the journal is not open access, it ensures accessibility to profound knowledge through institutional subscriptions. Researchers and scholars will find critical analyses and innovative research that are pivotal for both foundational knowledge and cutting-edge investigations in the neuroscience realm.

Adaptive Human Behavior and Physiology, published by Springer Heidelberg, is a pivotal journal in the fields of behavioral neuroscience, experimental and cognitive psychology, and physiology. With its ISSN 2198-7335, this quarterly journal serves as a forum for innovative research that explores the intricate relationships between human behavior and physiological processes. Although currently categorized within the Q4 and Q3 quartiles for various psychological and physiological domains, this journal has rapidly established itself as a significant resource for cutting-edge studies from 2015 to 2024. The journal’s commitment to high-quality research is reflected in its Scopus rankings, positioning it among noteworthy publications, particularly in experimental psychology and neuroscience. This journal is vital for researchers, professionals, and students seeking to deepen their understanding of adaptive behaviors and the underlying physiological mechanisms. Join the discourse and contribute to this evolving field through your scholarship in Adaptive Human Behavior and Physiology.

NEUROENDOCRINOLOGY LETTERS is a distinguished academic journal published by MAGHIRA & MAAS PUBLICATIONS, focusing on the intricate interplay between the nervous system and the endocrine system. Since its inception in 1979, the journal has provided a vital platform for researchers and practitioners in the fields of endocrinology, psychiatry, and neurology, making significant contributions to our understanding of neuroendocrine mechanisms and their clinical implications. Although currently categorized in the Q4 quartile across several disciplines, including Endocrine and Autonomic Systems and Neurology, the journal continues to strive for excellence in disseminating quality research. With an ISSN of 0172-780X and E-ISSN 2354-4716, it allows for global engagement, albeit not currently available as Open Access. The journal's impact on its respective fields is underscored by its steady publication trajectory from its initial years to 2024, making it an essential resource for students, professionals, and researchers seeking to explore the dynamic relationships within neuroendocrinology.

ENDOCRINE JOURNAL, published by the Japan Endocrine Society, is a pivotal resource for researchers and professionals in the field of endocrinology, diabetes, and metabolism. With a long history dating back to 1954, this journal encompasses a comprehensive range of topics including hormonal regulation, pathophysiology of endocrine diseases, and innovative therapeutic approaches. Despite its classification as open access, the journal remains a beacon of knowledge, with impressive rankings—Q2 in Endocrinology, Diabetes and Metabolism and Q3 in Endocrinology for 2023—ensuring it is a respected source in the academic community. It serves as a critical platform for the dissemination of cutting-edge research, encouraging collaboration and facilitating advancements in understanding complex endocrine disorders. By subscribing to this journal, researchers and students gain access to seminal studies, clinical insights, and a wealth of information that drives this vital field forward.